Orphan designation: orvepitant maleate Treatment of idiopathic pulmonary fibrosis, 21/11/2025 Positive

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 13, Status: Authorised

Download medicine data

Download website data in JSON data format

Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Date of authorisation: 26/03/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Fylrevy, estetrol, Date of authorisation: 26/03/2026, Status: Authorised

Union Product Database